Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Claims data suggest endometriosis ups risk of chronic opioid use

Publish date:: July 2, 2019

Key clinical point: Women with endometriosis are at increased risk of chronic opioid use, compared with those without endometriosis.

Major finding: The adjusted odds ratio for chronic opioid use among women with endometriosis versus those without was 3.76.

Study details: An observational study of more than 2.2 million women.

Disclosures: This study was funded by AbbVie. Dr. Chiuve is an employee of AbbVie, and she reported receiving stock/stock options.

Citation:

REPORTING FROM ACOG 2019

This Week's Must Reads

MDD: Modest improvements in female sexual functioning with adjunctive brexpiprazole,

Transcranial direct current stimulation not clinically relevant in MDD,

Interleukin-1 β and TNF-α hamper antidepressant response in MDD,

Impact of pimavanserin on anxious depression in patients with MDD,

Prior MDD moderates the association between endothelin-1 and post-ACS depressive symptoms,

Must Reads in Opioid Resource Center

Depression linked to persistent opioid use after hysterectomy,

Opioids, Benzodiazepines Carry Greater Risk of COPD-Related Hospitalization,

Medication Overuse Prevalent Among US Migraine Patients,

Pharmacist Stigma a Barrier to Rural Buprenorphine Access,

CDC finds that too little naloxone is dispensed,

All Specialties